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Brief Communications
Volume Expansion Enhances
Plasma Endothelin-1
Saad Abdel-Sayed, Hans Rudolf Brunner, and Juerg Nussberger
We hypothesized that acute volume expansion by saline
infusion triggers the release of endothelin-1. Bolus intra-
venous saline infusion (8 mL/min) in six groups of con-
scious Wistar rats and spontaneously hypertensive rats did
not change mean arterial pressure or heart rate (n  8 to
12). At 1 min after infusion, the plasma endothelin-1 level
was significantly increased in Wistar rats and in sponta-
neously hypertensive rats by 42% and 61%, respectively
(unpaired data). In 12 Wistar rats, the endothelin-1 level
increased from 0.68  0.13 to 1.19  0.17 fmol/mL
(mean  SEM, P  .0001, paired data). Thus, acute
volume load by rapid saline infusion increases plasma
endothelin-1 levels. Vasoconstriction induced by endothe-
lin-1 may counteract enhanced circumferential stretch cre-
ated by volume expansion. Am J Hypertens 2003;16:
1057–1061 © 2003 American Journal of Hypertension,
Ltd.
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E ndothelin-1 (ET-1) is a potent vasoconstrictor pep-tide hormone of 21 amino acids. It is predomi-nantly produced by vascular endothelial cells.1
Many factors are known to stimulate endothelin release,
such as hormones, growth and metabolic factors, hypoxia,
and mechanical forces acting on the vascular wall.2
Among the mechanical forces, vascular shear stress and
circumferential stretching may play a predominant role in
endothelin release.3,4 The circumferential expansion of the
blood vessels during the cardiac cycle is also known as
hoop stretch.
Fyhrquist et al5 showed that in anesthetized Wistar rats,
basal and volume-stimulated atrial natriuretic peptide
(ANP) release was decreased by pretreatment with endo-
thelin antibodies. They suggested that endothelin physio-
logically modulates ANP release. Furthermore, the
specific blockade of the endothelin ETA receptors blunts
the peak ANP response to rapid infusion of saline in
conscious Wistar rats.6 Thus, endothelin appears to stim-
ulate the ANP response to acute volume overload through
the ETA receptor.
At present, despite good evidence of the involvement of
endothelin in the physiologic ANP response to acute vol-
ume load, plasma endothelin concentrations have not been
measured under such conditions. Different rat models of
hypertension based on chronic volume overload such as
DOCA-salt or 1-kidney, 1-clip hypertension (Goldblatt
hypertension) (1K1C Goldblatt rats) present increased
plasma ET-1 levels.7–9 The present study investigates the
effect of acute volume load by rapid saline infusion on
plasma ET-1 levels in conscious normotensive Wistar and
spontaneously hypertensive rats (SHR).
Methods
Experimental Animals
Male Wistar rats and SHR of 8 weeks of age, weighing
220 to 246 g, were purchased from Iffa Credo (L’Arbresle,
France). Rats were housed in transparent plastic cages in a
quiet room at 22°C and maintained on standard rat chow
containing 0.22% sodium and 0.20% potassium and tap
water ad libitum. The Governmental Animal Care Com-
mittee approved the study protocols.
Twenty-four hours before the study day, rats were
anesthetized by inhalation of 2% halothane in oxygen. For
arterial blood pressure (BP) measurements and blood sam-
pling, polyethylene (PE) catheters were inserted into a
femoral artery. Catheters consisted of a 6-cm PE-10 intra-
vascular segment that was welded to a 25-cm PE-50
tubing. For saline infusions into the femoral vein, similar
catheters and tubings were used but the tip of the intra-
vascular segment was replaced by a less rigid 2-cm sili-
cone tubing of 0.3-mm internal and 0.6-mm external
diameter (Ulrich Swiss, St. Gallen, Switzerland). The
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PE-50 tubings of both the intra-arterial and the intravenous
catheters were threaded under the skin and exteriorized at
the back of the neck. The catheterized rats were housed
individually in plastic cages and kept in a quiet place at
22°C.
Study Protocol
On the study day, conscious rats were placed in a plastic
tube for partial immobilization. After a 20-min rest, mean
arterial pressure (MAP) and heart rate (HR) were moni-
tored using the Notocord computerized system (Paris,
France). Then 2 mL of arterial blood was collected for
endothelin measurement from control Wistar rats (group
A, n  11) and control SHR (group B, n  8).
To four different groups of Wistar rats and SHR, 8 or 10
mL of 0.9% saline were rapidly infused in 1 min (Sage
Instruments, Cambridge, MA). At 1 min after the end of
the saline infusion, arterial plasma ET-1 was measured,
and MAP and HR were registered. In Wistar rats, one
group (C, n  11) received 8 mL of saline without being
bled for endothelin measurement before the saline infu-
sion. Another group (D, n  12) consisting of two lots of
7 and 5 Wistar rats received 10 mL of saline after an initial
2-mL bleeding for endothelin measurement. In SHR, one
group (E, n  11) received 10 mL of saline without initial
bleeding for endothelin measurement and another group
(F, n  9) received 10 mL of saline after an initial 2-ml
bleeding.
Blood Sampling
Two milliliters of blood were collected from the femoral
artery of conscious rats through an indwelling catheter.
Blood was immediately transferred into prechilled glass
tubes containing tripotassium ethylenediaminetetraacetate
to achieve by mixture a final plasma concentration of 7
mmol/L. Blood was centrifuged at 4°C for 10 min at 1660
g. Plasma (1.2 mL) was stored in polypropylene tubes at
20°C.
Determination of Dilution Factor
Hematocrit (Hct) was assessed in heparinized capillary
tubes (Baxter Healthcare Corp., Dearfield, IL) after 10 min
of centrifugation in a bench-top microcentrifuge (Hettich,
L’Abergement, Switzerland). The plasma dilution factor
(DF) due to saline infusion was defined as the ratio of the
relative plasma volume after infusion (100  HctA) over
the relative plasma volume before infusion (100  HctB):
DF  (100  HctA)/(100  HctB).
Measurement of ET-1
Plasma immunoreactive ET-1 was measured by liquid
phase extraction and subsequent ELISA, as previously
described in detail.9 Briefly, endothelin was extracted
from 1 mL of plasma by acetone-HCl (recovery 55% to
75%) and specifically quantitated by a sandwich-type
ELISA. The detection limit in plasma was 0.05 fmol/mL.
Endothelin concentrations after saline infusion were cor-
rected for plasma dilution by multiplying measured levels
with the DF, which varied between 1.04 and 1.26.
Statistical Analysis
For comparison of hemodynamic means, a one-way anal-
ysis of variance was performed followed by Tukey’s mul-
tiple comparison test. Endothelin concentrations before
and after saline infusion were evaluated by unpaired or
paired Student t test as appropriate. The significance level
was P  .05.
Results
Endothelin Response
to Acute Volume Load
Fig. 1 demonstrates the effect of saline infusion in Wistar
rats (left panel) and SHR (right panel) for unpaired and
paired data (upper and lower panel, respectively).
In normotensive Wistar rats, plasma ET-1 was 42%
higher after saline infusion (8 mL) at 1.26 0.13 fmol/mL
(group C) as compared to control rats at 0.89  0.09
fmol/mL (group A) (P  .05). Fig. 1 also demonstrates
individual increases in plasma ET-1 after saline infusion
(10 mL) in the 12 rats where ET-1 was measured both
before and after saline infusion (group D). Plasma ET-1
increased from 0.68  0.13 to 1.19  0.17 fmol/mL (P 
.0001). The average increase was 84%. This increase in
ET-1 after 10 mL of saline was greater than the enhance-
ment found after infusion of 8 mL of saline (P  .05,
unpaired t test, rank order comparisons for 8-mL infu-
sions).
In the SHR, plasma ET-1 was 61% higher after saline
infusion at 1.05 0.14 fmol/mL (group E) as compared to
control SHR at 0.65  0.03 (group B) (P  .05). Fig. 1
(lower right panel) also depicts individual changes in
plasma ET-1 after saline infusion in the nine SHR whose
ET-1 was measured both before and after saline infusion
(group F). Mean plasma ET-1 concentration increased
from 0.64 0.03 to 0.81 0.03 fmol/mL (P .02, paired
t test). The average increase was 28%. Among the nine
SHR of this group F, six increased and two decreased
ET-1 levels in response to saline infusion, whereas one rat
kept ET-1 unchanged.
BP and Heart Rate Response
Table 1 shows effects of blood sampling and saline infu-
sion on BP and heart rate in Wistar rats and SHR. After the
initial 2-mL bleeding, Wistar rats tended to increase heart
rate and fairly maintain BP, whereas SHR had reduced
heart rate (P  .05) and their BP decreased (P  .05).
Saline infusion reversed these hemodynamic changes to-
ward baseline. Immediately after the initial blood sam-
pling, BP in SHR was considerably lower than in unbled
control SHR (P  .01). No such difference was found in
Wistar rats.
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Discussion
Acute volume load by rapid infusion of saline increases
plasma ET-1 levels in Wistar rats and in SHR. In Wistar
rats, a net volume enhancement of 8 mL led to similar final
ET-1 levels of 1.2 fmol/mL in two differently tested
groups of rats (C without initial bleeding, D with 2 mL of
initial bleeding). Nevertheless, the 10-mL saline infusion
after an initial 2-mL bleeding increased the endogenous
ET-1 by 84% (paired data, 12/12 rats increased plasma
ET-1), ie, more than the 8-mL saline infusion without
blood sampling at baseline (42%, unpaired data). This
enhanced ET-1 response may be due to various reasons.
The baseline 2-mL hemorrhage certainly stimulated renal
renin secretion and hence increased angiotensin II levels,
which are known to trigger ET-1 release.10 Kowano et al11
FIG. 1. (Upper left panel) Intravenous 1-min infusions of 8 mL of physiologic saline in Wistar rats enhances plasma immunoreactive
endothelin-1 by 42% (*P  .05, unpaired t test). (Upper right panel) Intravenous 1-min infusions of 10 mL of physiologic saline in SHR
enhances plasma endothelin-1 by 61% (*P .05, unpaired t test). (Lower left panel) Plasma endothelin-1 levels in 12 normotensive Wistar
rats before and after 1-min intravenous infusions of 10 mL of physiologic saline: endothelin-1 levels were increased in all rats at the end of
the infusion (P  .0001). The lowest five levels represent a complete second lot of Wistar rats. (Lower right panel) Plasma endothelin-1
levels in nine SHR before and after 1-min intravenous infusions of 10mL of physiologic saline: endothelin-1 levels were significantly increased
at the end of the infusion despite the lack of response in three rats (P  .02). Mean  SEM, n  8 to 12, *P  .05, ***P  .0001.
Table 1. Blood pressure and heart rate in Wistar rats and SHR (mean  SD, n  8 to 12)
Rat Species
Blood Pressure (mm Hg) Heart Rate (min1)
Baseline
Blood
Sampled*
Saline
Infused Baseline
Blood
Sampled*
Saline
Infused
Wistar
Not bled 119  3 119  3 117  2 446  8 446  8 428  8
Bled 121  3 113  4 108  3 448  4 475  5 437  3
SHR
Not bled 154  2 156  1 153  1 398  5 387  7 401  8
Bled 152  8 118  10†‡ 137  6 410  9 332  34† 365  19
SHR  spontaneously hypertensive rats.
* Ten l of blood for hematocrit measurement in all rats; two ml of blood for endothelin-1 measurement in “bled” rats.
† P  .05 versus baseline, ‡ P  .01 versus not bled.
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have measured concomitantly increased plasma renin ac-
tivity and ET-1 concentrations in anesthetized Wistar rats
after withdrawing a similar volume of blood (7 mL/kg). In
our conscious rats, 10 mL of saline was infused after a
2-min period of hypovolemia. The enhanced ET-1 re-
sponse may, therefore, be due to both the 2-mL hemor-
rhage at baseline and to the larger volume of saline infused
(10 v 8 mL).
Contrasting with previous results,9 baseline ET-1 levels
in Wistar rats were not higher than in SHR. Very low ET-1
concentrations in one lot of rats enhanced the scatter of
ET-1 levels in Wistar rats, whereas SHR had consistently
low plasma ET-1. In SHR, all infusions consisted of 10
mL of saline. The infusions increased the low endogenous
plasma ET-1 levels by merely 28% when 2 mL of blood
were collected before saline infusion, and by 61% without
prior blood sampling. In six of nine SHR, saline infusion
actually increased plasma ET-1, whereas two SHR re-
sponded with a slight decrease in ET-1 and in one SHR,
the ET-1 level remained unchanged.
Our findings in conscious rats are consistent with the
modulatory effect of endothelin on ANP release after rapid
saline infusion, as previously demonstrated by the use of
endothelin antibodies5 or ETA receptor blockers.6 The
rapid volume expansion by saline infusion triggers a com-
pensatory release of ANP that is lost in the presence of
endothelin antibodies or ETA receptor blockers.5,6 Circu-
lating endothelin may directly stimulate atrial myocytes to
secrete ANP or indirectly by vasoconstriction and volume
centralization. It was therefore likely that saline infusion
would stimulate endothelin release. Our measurements in
Wistar rats and SHR verify this hypothesis. We used the
same infusion technique as did Fyhrquist et al5 to obtain
conclusive results. Baertschi et al6 had also observed an
ET-1-mediated increase in plasma ANP after rapid saline
infusion (6.6 mL/min) and even to slow infusions (3.3
mL/8 min). It would be of interest to confirm our finding
that circulating ET-1 also increased after the more physi-
ologic slow infusions. Nevertheless, previous work in rats
also suggested7–9 that higher plasma ET-1 levels prevailed
in rat models in which BP predominantly depended on
enhanced circulating volume (DOCA-salt, 1K1C). Lower
plasma ET-1 levels were found in SHR,9 where enhanced
vasoconstriction rather than volume expansion maintains
high BP. Clinical studies are now awaited to confirm our
findings in humans.
Interestingly, our SHR responded to a 2-mL blood
withdrawal with a decrease in mean arterial pressure of 40
mm Hg. Unlike Wistar rats, SHR were unable to maintain
BP by a rapid baroreflex increase in heart rate. One minute
after blood sampling, heart rate of SHR was actually
decreased. Albeit SHR have a reduced baroreflex sensitiv-
ity, it also appears that SHR as a vasoconstrictor model of
hypertension may respond more drastically to a 2-mL
blood loss. The circulating volume before blood sampling
may be reduced in SHR and therefore a relatively large
blood loss is sensed. Furthermore, an already maximally
constricted vasculature may have little functional reserve
to respond to vasoconstrictor hormones such as norepi-
nephrine, angiotensin II, or ET-1.
We did not measure circumferential stretch (hoop
stretch) in the present experiments. But our results are
compatible with the release of ET-1 in response to aug-
mented circumferential stretch due to volume expansion.
Lauth et al12 reported upregulated preproendothelin-1
mRNA together with enhanced vascular endothelial ET-1
content in response to increased intraluminal pressure in
rabbit carotid arteries. Ziegler et al4 found in an artificial
device for shear and stretch modeling that shear stress
transiently increased ET-1 mRNA. The hoop stretch con-
cept would make sense. Stretched endothelial cells release
ET-1 to induce vasoconstriction, which protects endothe-
lial cells against further stretching. High and low circulat-
ing levels of ET-1 in different rat models of hypertension
could be easily explained by expanded volume or predom-
inant vasoconstriction.
In conclusion, rapid infusion of saline increases ET-1
concentrations in the circulating blood of Wistar rats and
SHR. The volume-induced stretching of endothelial cells
may cause a release of the protecting vasoconstrictor
ET-1.
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